Bausch Health Companies Inc. (BHC)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenues | 2,530 | 2,259 | 2,510 | 2,403 |
| Cost of goods sold (excluding amortization and impairments of intangible assets) and cost of other revenues | - | 701 | 682 | 708 |
| Selling, general and administrative | 894 | 867 | 850 | 832 |
| Research and development | 159 | 143 | 146 | 156 |
| Other (income) expense, net | 18 | -15 | -225 | -20 |
| Cost of goods sold (excluding amortization and impairments of intangible assets) and cost of other revenues-Product | 748 | - | - | - |
| Cost of goods sold (excluding amortization and impairments of intangible assets) and cost of other revenues-Product And Service Other | 16 | - | - | - |
| Asset impairments | - | - | - | 5 |
| Restructuring, integration and separation costs | 31 | 1 | 1 | 12 |
| Amortization of intangible assets | 256 | 256 | 274 | 270 |
| Total expenses | 2,086 | 1,983 | 2,192 | 2,014 |
| Operating income | 444 | 276 | 318 | 389 |
| Interest income | 13 | 11 | 7 | 8 |
| Interest expense | 465 | 330 | 346 | 350 |
| Gain on extinguishment of debt | 178 | - | - | 12 |
| Foreign exchange and other | -30 | -4 | - | -11 |
| Income (loss) before income taxes | 140 | -47 | -21 | 48 |
| Provision for income taxes | 12 | 39 | 71 | 49 |
| Net income (loss) | 128 | -86 | -92 | -1 |
| Net loss attributable to noncontrolling interest | -20 | -28 | -7 | -11 |
| Net income (loss) attributable to bausch health companies inc | 148 | -58 | -85 | 10 |
| Basic earnings (loss) per share attributable to bausch health companies inc. (in dollars per share) | 0.4 | -0.16 | -0.23 | 0.03 |
| Basic weighted-average common shares (in shares) | 370,900,000 | 369,600,000 | 368,400,000 | 367,900,000 |
| Diluted earnings (loss) per share attributable to bausch health companies inc. (in dollars per share) | 0.4 | -0.16 | -0.23 | 0.03 |
| Diluted weighted-average common shares (in shares) | 373,100,000 | 369,600,000 | 368,400,000 | 370,200,000 |